Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ABT

ABT - Abbott Laboratories Stock Price, Fair Value and News

$106.06-2.21 (-2.04%)
Market Closed

61/100

ABT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

61/100

ABT

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$113.33

Target 3M

$108.82

Target 6M

$110.32

ABT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ABT Price Action

Last 7 days

-12.1%

Last 30 days

-14.9%

Last 90 days

-14.9%

Trailing 12 Months

-16.7%

ABT RSI Chart

ABT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ABT Valuation

Market Cap

184.8B

Price/Earnings (Trailing)

13.22

Price/Sales (Trailing)

4.21

EV/EBITDA

19.79

Price/Free Cashflow

26.71

ABT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$113.33

Target 3M

$108.82

Target 6M

$110.32

ABT Fundamentals

ABT Revenue

Revenue (TTM)

43.8B

Rev. Growth (Yr)

6.9%

Rev. Growth (Qtr)

2.04%

ABT Earnings

Earnings (TTM)

14.0B

Earnings Growth (Yr)

-0.12%

Earnings Growth (Qtr)

-7.59%

ABT Profitability

EBT Margin

18.56%

Return on Equity

27.43%

Return on Assets

16.6%

Free Cashflow Yield

3.74%

ABT Investor Care

Dividend Yield

2.23%

Dividend/Share (TTM)

2.36

Shares Dilution (1Y)

0.15%

Diluted EPS (TTM)

7.97

ABT Alerts

  • 1 major insider buys recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202542.3B43.1B43.8B0
202440.3B40.7B41.2B42.0B
202341.5B40.2B40.0B40.1B
202244.5B45.5B45.0B43.7B
202137.3B40.2B42.3B43.1B
202032.1B31.4B32.2B34.6B
201930.7B30.9B31.4B31.9B
201828.4B29.6B30.4B30.6B
201722.3B23.6B25.1B27.4B
201620.4B20.6B20.7B20.9B
201520.4B20.5B20.6B20.4B
201419.6B19.7B20.0B20.2B
201321.1B20.7B20.2B19.7B
201235.1B30.8B26.2B21.5B
201136.5B37.3B38.4B38.9B
201000035.2B
Get all data in R, Python etc through our Historical Stock Data APIs

About Abbott Laboratories

ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
 CEO
 WEBSITEabbott.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES65535

Abbott Laboratories Frequently Asked Questions

ABT is the stock ticker symbol of Abbott Laboratories. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Abbott Laboratories is 184.77 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check ABT's fair value in chart for subscribers.

The fair value guage provides a quick view whether ABT is over valued or under valued. Whether Abbott Laboratories is cheap or expensive depends on the assumptions which impact Abbott Laboratories's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ABT.

As of Wed Jan 28 2026, ABT's PE ratio (Price to Earnings) is 13.22 and Price to Sales (PS) ratio is 4.21. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ABT PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Abbott Laboratories has provided 0.108 (multiply by 100 for percentage) rate of return.